Kestra Private Wealth Services LLC lifted its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 2.7% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 46,766 shares of the medical equipment provider's stock after buying an additional 1,248 shares during the quarter. Kestra Private Wealth Services LLC's holdings in Intuitive Surgical were worth $23,162,000 as of its most recent SEC filing.
Several other institutional investors also recently modified their holdings of the business. Hurley Capital LLC purchased a new position in Intuitive Surgical in the fourth quarter worth about $28,000. Parvin Asset Management LLC bought a new stake in shares of Intuitive Surgical during the fourth quarter valued at approximately $26,000. Chilton Capital Management LLC raised its holdings in Intuitive Surgical by 614.3% in the 1st quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider's stock worth $25,000 after acquiring an additional 43 shares during the last quarter. Global Financial Private Client LLC lifted its position in Intuitive Surgical by 253.3% in the 1st quarter. Global Financial Private Client LLC now owns 53 shares of the medical equipment provider's stock valued at $26,000 after acquiring an additional 38 shares in the last quarter. Finally, Elite Financial Inc. purchased a new stake in Intuitive Surgical during the 1st quarter valued at $26,000. 83.64% of the stock is currently owned by institutional investors.
Analyst Upgrades and Downgrades
ISRG has been the topic of several research analyst reports. Royal Bank Of Canada lowered their price target on Intuitive Surgical from $630.00 to $605.00 and set an "outperform" rating on the stock in a report on Wednesday, April 23rd. Truist Financial dropped their target price on Intuitive Surgical from $605.00 to $590.00 and set a "buy" rating on the stock in a research report on Wednesday, April 23rd. Citigroup restated a "buy" rating and set a $650.00 price target (up from $590.00) on shares of Intuitive Surgical in a research note on Thursday, May 22nd. Erste Group Bank raised shares of Intuitive Surgical from a "hold" rating to a "buy" rating in a report on Thursday, June 5th. Finally, BTIG Research set a $566.00 price target on shares of Intuitive Surgical and gave the stock a "buy" rating in a research report on Monday, July 14th. One research analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have assigned a buy rating to the stock. Based on data from MarketBeat, Intuitive Surgical has an average rating of "Moderate Buy" and a consensus target price of $592.86.
Get Our Latest Stock Analysis on Intuitive Surgical
Insider Buying and Selling at Intuitive Surgical
In other Intuitive Surgical news, EVP Gary Loeb sold 1,700 shares of Intuitive Surgical stock in a transaction dated Friday, April 25th. The stock was sold at an average price of $513.18, for a total value of $872,406.00. Following the transaction, the executive vice president owned 2,245 shares in the company, valued at $1,152,089.10. The trade was a 43.09% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, SVP Mark Brosius sold 216 shares of the firm's stock in a transaction dated Friday, June 6th. The shares were sold at an average price of $563.11, for a total transaction of $121,631.76. Following the completion of the sale, the senior vice president owned 907 shares in the company, valued at $510,740.77. This represents a 19.23% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 4,998 shares of company stock valued at $2,611,577 in the last ninety days. Company insiders own 0.70% of the company's stock.
Intuitive Surgical Stock Performance
ISRG stock traded up $2.46 during mid-day trading on Friday, reaching $518.62. 1,903,997 shares of the stock traded hands, compared to its average volume of 1,666,315. The business has a 50-day moving average price of $535.90 and a two-hundred day moving average price of $536.21. The stock has a market capitalization of $185.88 billion, a PE ratio of 76.04, a PEG ratio of 5.50 and a beta of 1.64. Intuitive Surgical, Inc. has a one year low of $425.00 and a one year high of $616.00.
Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share for the quarter, topping analysts' consensus estimates of $1.71 by $0.10. The business had revenue of $2.25 billion for the quarter, compared to analyst estimates of $2.19 billion. Intuitive Surgical had a return on equity of 14.43% and a net margin of 28.41%. During the same quarter last year, the firm posted $1.50 earnings per share. On average, equities analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.
About Intuitive Surgical
(
Free Report)
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Further Reading

Before you consider Intuitive Surgical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Intuitive Surgical wasn't on the list.
While Intuitive Surgical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.